Daphnegiravone D synergistically inhibits liver cancer in combination with oxaliplatin in vitro and in vivoOA
Objective:Daphnegiravone D(DGD),a prenylated flavonoid from Daphne giraldii Nitsche,a plant whose roots and stem are used in Chinese medicine,exerts an inhibitory effect on liver cancer cells.The protein kinase ataxia telangiectasia-mutated and Rad3-related(ATR)is an important component of the DNA damage response,and its inhibition enhances the sensitivity of some cancer cells to DNA-damaging drugs.Oxaliplatin(OXA)is a third-generation,platinum-based anticancer drug that exerts its inhibitory effects on liver cancer cells by inhibiting DNA synthesis.Owing to the fact that most patients develop drug resistance,finding novel treatments for liver cancer is urgent.In a previous study,DGD was shown to exert anti-tumor effects as a potential ATR kinase inhibitor.This study investigated the mechanism of action of DGD and its combination with OXA in liver cancer.Methods:HepG2 and Hep3B cells were used to evaluate the inhibitory effects of DGD on liver cancer.Cellular thermal shift assay,co-immunoprecipitation,and western blotting were used to confirm the impact of DGD on DNA damage.The methyl thiazolyl tetrazolium(MTT)assay was performed,and the resulting data were used to calculate drug synergy scores.Acridine orange/ethidium bromide staining,Annexin V/propidium iodide staining,reactive oxygen species–related staining,and western blotting were performed to assess the efficacy of the combination of DGD and OXA.An in vivo tumor xenograft model in nude mice was used to investigate the efficacy of this combination.Hematoxylin–eosin staining and immunohistochemistry were performed to observe the condition of tissues in vivo.Results:DGD inhibited liver cancer cells by affecting the formation of the ATR-ATRIP complex and downregulating the activator protein TopBP1.We found that DGD and OXA showed synergistic growth-inhibitory effects in liver cancer cells in vitro.DGD and OXA showed synergistic growth-inhibitory effects in liver cancer cells in vitro and showed lower cytotoxicity toward L-02 cells than an equi-effective higher concentration of OXA under the tested conditions in normal liver cells.The combination was associated with enhanced apoptosis,mitochondrial dysfunction,and oxidative stress.Further experiments suggested that DGD may enhance OXA-induced DNA damage,at least partly in association with suppression of ATR-related signaling.Consistent with the above results,DGD enhanced the antitumor efficacy of OXA in vivo without causing overt additional toxicity under the present experimental conditions.Conclusion:Our findings indicate that DGD enhances the antitumor activity of OXA against liver cancer,with the in vitro synergistic effect being associated,at least partly,with suppression of ATR-related signaling,enhanced DNA damage,and oxidative stress.DGD also improved the antitumor efficacy of OXA in the xenograft model without overt additional toxicity.
Yu-Jue Wang;Jiao-Yang Hou;Xin-Ye Wang;Hong-Fei Chen;Shuang Qiu;Qing-Bo Liu;Xiao-Xiao Huang;Guo-Dong Yao;Shao-Jiang Song
Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang Pharmaceutical University,Shenyang,China School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang,China Engineering Research Center of Natural Medicine Active Molecule Research&Development,Liaoning,Shenyang Pharmaceutical University,Shenyang,China Key Laboratory of Natural Bioactive Compounds Discovery&Modification,Shenyang,Shenyang Pharmaceutical University,Shenyang,ChinaKey Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang Pharmaceutical University,Shenyang,China School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang,China Engineering Research Center of Natural Medicine Active Molecule Research&Development,Liaoning,Shenyang Pharmaceutical University,Shenyang,China Key Laboratory of Natural Bioactive Compounds Discovery&Modification,Shenyang,Shenyang Pharmaceutical University,Shenyang,ChinaKey Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang Pharmaceutical University,Shenyang,China School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang,China Engineering Research Center of Natural Medicine Active Molecule Research&Development,Liaoning,Shenyang Pharmaceutical University,Shenyang,China Key Laboratory of Natural Bioactive Compounds Discovery&Modification,Shenyang,Shenyang Pharmaceutical University,Shenyang,ChinaKey Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang Pharmaceutical University,Shenyang,China School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang,China Engineering Research Center of Natural Medicine Active Molecule Research&Development,Liaoning,Shenyang Pharmaceutical University,Shenyang,China Key Laboratory of Natural Bioactive Compounds Discovery&Modification,Shenyang,Shenyang Pharmaceutical University,Shenyang,ChinaKey Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang Pharmaceutical University,Shenyang,China School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang,China Engineering Research Center of Natural Medicine Active Molecule Research&Development,Liaoning,Shenyang Pharmaceutical University,Shenyang,China Key Laboratory of Natural Bioactive Compounds Discovery&Modification,Shenyang,Shenyang Pharmaceutical University,Shenyang,ChinaKey Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang Pharmaceutical University,Shenyang,China School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang,China Engineering Research Center of Natural Medicine Active Molecule Research&Development,Liaoning,Shenyang Pharmaceutical University,Shenyang,China Key Laboratory of Natural Bioactive Compounds Discovery&Modification,Shenyang,Shenyang Pharmaceutical University,Shenyang,ChinaKey Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang Pharmaceutical University,Shenyang,China School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang,China Engineering Research Center of Natural Medicine Active Molecule Research&Development,Liaoning,Shenyang Pharmaceutical University,Shenyang,China Key Laboratory of Natural Bioactive Compounds Discovery&Modification,Shenyang,Shenyang Pharmaceutical University,Shenyang,ChinaKey Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang Pharmaceutical University,Shenyang,China School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang,China Engineering Research Center of Natural Medicine Active Molecule Research&Development,Liaoning,Shenyang Pharmaceutical University,Shenyang,China Key Laboratory of Natural Bioactive Compounds Discovery&Modification,Shenyang,Shenyang Pharmaceutical University,Shenyang,ChinaKey Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang Pharmaceutical University,Shenyang,China School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang,China Engineering Research Center of Natural Medicine Active Molecule Research&Development,Liaoning,Shenyang Pharmaceutical University,Shenyang,China Key Laboratory of Natural Bioactive Compounds Discovery&Modification,Shenyang,Shenyang Pharmaceutical University,Shenyang,China
医药卫生
ATRDaphnegiravone DDrug combinationLiver cancerOxaliplatin
《Acupuncture and Herbal Medicine》 2026 (3)
P.372-386,15
supported by the National Natural Science Foundation of China(81973528,82273821)LiaoNing Revitalization Talents Program(XLYC2503156)Youth Innovation Team Scientific Research Project of Liaoning Provincial Department of Education(LT222410163052)Natural Science Foundation of Liaoning province(2022-MS-244)Young Elite Scientists Sponsorship Program by CACM(2023-QNRC2-B24)Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine(ZYYCXTD-D-202208)Plan of Shenyang Young and Middle-aged Science and Technology Innovation Talents Support(RC210451)the Scientific Research Fund Project of Liaoning Provincial Department of Education(LJKZ0907)China Postdoctoral Science Foundation(2019M661135)Song Shaojiang Expert Workstation of Yunnan Province(202305 AF150030)the Outstanding and Excellent Youth Talent Support Program of Shenyang Pharmaceutical University(ZQ202201,YQ202104)the Liaoning Revitalization Talents Program(No.XLYC2002066)Science and Technology Planning Project of Liaoning Province(2021JH1/10400049).
评论